Insulin resistance and risk of vascular events, interventions and mortality in type 1 diabetes

CONCLUSIONS: Insulin resistance as measured by eGDR is an additional risk factor for cardiovascular disease in individuals with type 1 diabetes. Modification of insulin resistance by lifestyle interventions or pharmacological treatment could be a viable therapeutic target to lower the risk of cardiovascular disease.PMID:34636745 | DOI:10.1530/EJE-21-0636

Source: European Journal of Endocrinology - October 12, 2021 Category: Endocrinology Authors: Marga A G Helmink Marieke de Vries Frank L J Visseren Wendela L de Ranitz Harold W de Valk Jan Westerink Source Type: research